Getinge (OTCMKTS:GNGBY – Get Free Report) shares passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $20.58 and traded as low as $20.50. Getinge shares last traded at $20.88, with a volume of 724 shares changing hands.
Analysts Set New Price Targets
Separately, Zacks Research raised shares of Getinge to a “hold” rating in a research note on Thursday, April 23rd. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold”.
Check Out Our Latest Report on GNGBY
Getinge Stock Up 3.7%
Getinge Company Profile
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Further Reading
- Five stocks we like better than Getinge
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
